Bank of New York Mellon Corp reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,512,681 shares of the medical equipment provider’s stock after selling 101,352 shares during the period. Bank of New York Mellon Corp’s holdings in Intuitive Surgical were worth $1,414,916,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Shell Asset Management Co. increased its stake in shares of Intuitive Surgical by 0.9% in the first quarter. Shell Asset Management Co. now owns 7,145 shares of the medical equipment provider’s stock worth $5,476,000 after buying an additional 65 shares in the last quarter. Glen Harbor Capital Management LLC increased its stake in shares of Intuitive Surgical by 2.4% in the first quarter. Glen Harbor Capital Management LLC now owns 12,912 shares of the medical equipment provider’s stock worth $9,897,000 after buying an additional 304 shares in the last quarter. Meritage Portfolio Management increased its stake in shares of Intuitive Surgical by 0.6% in the first quarter. Meritage Portfolio Management now owns 6,795 shares of the medical equipment provider’s stock worth $5,208,000 after buying an additional 43 shares in the last quarter. Profund Advisors LLC increased its stake in shares of Intuitive Surgical by 6.7% in the first quarter. Profund Advisors LLC now owns 3,525 shares of the medical equipment provider’s stock worth $2,702,000 after buying an additional 222 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. increased its stake in shares of Intuitive Surgical by 3.7% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,033 shares of the medical equipment provider’s stock worth $740,000 after buying an additional 37 shares in the last quarter. 96.08% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at 985.37 on Wednesday. The firm has a market cap of $36.61 billion, a PE ratio of 47.20 and a beta of 0.39. Intuitive Surgical, Inc. has a 52 week low of $610.71 and a 52 week high of $990.44. The firm’s 50 day moving average price is $942.88 and its 200-day moving average price is $840.08. Shares of Intuitive Surgical are set to split on Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly issued shares will be distributed to shareholders after the closing bell on Wednesday, August 30th.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The firm had revenue of $756.20 million for the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The business’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.62 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post $23.92 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Intuitive Surgical, Inc. (ISRG) Position Lowered by Bank of New York Mellon Corp” was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.watchlistnews.com/intuitive-surgical-inc-isrg-position-lowered-by-bank-of-new-york-mellon-corp/1495311.html.

A number of equities research analysts have recently commented on the company. Vetr downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $1,006.51 price objective for the company. in a research report on Wednesday. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $1,050.00 price objective on shares of Intuitive Surgical in a research report on Friday, July 21st. Barclays PLC lifted their target price on Intuitive Surgical from $870.00 to $1,000.00 and gave the company an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. J P Morgan Chase & Co reiterated an “overweight” rating and issued a $1,050.00 target price on shares of Intuitive Surgical in a report on Friday, July 21st. Finally, BidaskClub upgraded Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a report on Friday, June 23rd. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $979.79.

In other Intuitive Surgical news, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the completion of the sale, the senior vice president now directly owns 3,046 shares in the company, valued at $2,702,076.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Curet Myriam sold 1,202 shares of the company’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $950.20, for a total transaction of $1,142,140.40. Following the sale, the senior vice president now owns 1,428 shares of the company’s stock, valued at $1,356,885.60. The disclosure for this sale can be found here. Insiders have sold 34,065 shares of company stock worth $31,659,090 over the last three months. Company insiders own 2.50% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.